Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Clinical trial NCT05942001 · RECRUITING

Trial details

NCT number: NCT05942001
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Prostate Cancer

Start date: 2023-08-03
Primary completion: 2025-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.